| Bioactivity | Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. Cyclo(glycyl-L-leucyl) inhibits the development of Morphine induced pain relief as well as dopamine receptor supersensitivity in rats. Cyclo(glycyl-L-leucyl) has the potential for the prevention of tardive and/or L-DOPA (HY-N0304)-induced dyskinesias[1][2]. |
| Name | Cyclo(glycyl-L-leucyl) |
| CAS | 5845-67-0 |
| Formula | C8H14N2O2 |
| Molar Mass | 170.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Cyclo(glycyl-L-leucyl)
CAS: 5845-67-0 F: C8H14N2O2 W: 170.21
Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminer
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.